Boston Scientific (BSX) Equity Average (2009 - 2026)
Boston Scientific recorded quarterly Equity Average of $25.2 billion in Q1 2026, up 5.17% quarter-over-quarter from $23.9 billion in Q4 2025, and up 13.84% year-over-year from $22.1 billion in Q1 2025.
Boston Scientific's Equity Average history runs 18 years deep, the most recent figure standing at $25.2 billion for Q1 2026.
- In Q1 2026, Equity Average rose 13.84% year-over-year to $25.2 billion; the TTM figure through Mar 2026 stood at $25.2 billion (up 13.84% YoY), while the FY2025 annual figure was $23.0 billion, up 11.39% from the prior year.
- Equity Average came in at $25.2 billion for Q1 2026 at Boston Scientific, up from $23.9 billion in the prior quarter.
- In the past five years, Equity Average ranged from a high of $25.2 billion in Q1 2026 to a low of $62.5 million in Q2 2024.
- A 5-year average of $13.9 billion and a median of $10.9 billion in 2025 frame the typical range for Equity Average.
- On a YoY basis, Equity Average climbed as much as 17408.8% in 2025 and fell as far as 9.26% in 2025.
- Boston Scientific's Equity Average stood at $8.4 billion in 2022, then jumped by 128.89% to $19.3 billion in 2023, then climbed by 10.52% to $21.4 billion in 2024, then increased by 12.02% to $23.9 billion in 2025, then gained by 5.17% to $25.2 billion in 2026.
- According to Business Quant data, Equity Average over the past three periods registered $25.2 billion, $23.9 billion, and $11.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 12.69 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.17 Bn |
| Dec 31, 2025 | 23.93 Bn |
| Sep 30, 2025 | 11.54 Bn |
| Jun 30, 2025 | 10.94 Bn |
| Mar 31, 2025 | 22.11 Bn |
| Dec 31, 2024 | 21.36 Bn |
| Sep 30, 2024 | 10.56 Bn |
| Jun 30, 2024 | 62.50 Mn |
| Mar 31, 2024 | 9.75 Bn |
| Dec 31, 2023 | 19.33 Bn |
| Sep 30, 2023 | 8.44 Bn |
| Dec 31, 2022 | 8.45 Bn |
| Mar 31, 2022 | 8.90 Bn |
| Dec 31, 2021 | 7.11 Bn |
| Sep 30, 2020 | 7.85 Bn |
| Jun 30, 2020 | -793.00 Mn |
| Mar 31, 2020 | -723.50 Mn |
| Dec 31, 2019 | -2.99 Bn |
| Sep 30, 2019 | -3.98 Bn |
| Jun 30, 2019 | -4.12 Bn |
| Mar 31, 2019 | 5.41 Bn |
| Dec 31, 2018 | 8.69 Bn |
| Sep 30, 2018 | -846.00 Mn |
| Jun 30, 2018 | 7.73 Bn |
| Mar 31, 2018 | 8.60 Bn |
| Dec 31, 2017 | 3.80 Bn |
| Sep 30, 2017 | 7.41 Bn |
| Jun 30, 2017 | 7.14 Bn |
| Mar 31, 2017 | 2.67 Bn |
| Dec 31, 2016 | 2.38 Bn |
| Sep 30, 2016 | 6.35 Bn |
| Jun 30, 2016 | 6.34 Bn |
| Mar 31, 2016 | 3.27 Bn |
| Dec 31, 2015 | 3.25 Bn |
| Sep 30, 2015 | 6.50 Bn |
| Jun 30, 2015 | 6.54 Bn |
| Mar 31, 2015 | 11.60 Bn |
| Dec 31, 2014 | 11.70 Bn |
| Sep 30, 2014 | 6.62 Bn |
| Jun 30, 2014 | 6.54 Bn |
| Mar 31, 2014 | 3.28 Bn |
| Dec 31, 2013 | 3.29 Bn |
| Sep 30, 2013 | 6.58 Bn |
| Jun 30, 2013 | 6.55 Bn |
| Mar 31, 2013 | 2.71 Bn |
| Dec 31, 2012 | 2.87 Bn |
| Sep 30, 2012 | 7.28 Bn |
| Jun 30, 2012 | 9.56 Bn |
| Mar 31, 2012 | 5.63 Bn |
| Dec 31, 2011 | 5.69 Bn |
| Sep 30, 2011 | 11.53 Bn |
| Jun 30, 2011 | 11.45 Bn |
| Mar 31, 2011 | 5.62 Bn |
| Dec 31, 2010 | 5.45 Bn |
| Sep 30, 2010 | 10.97 Bn |
| Jun 30, 2010 | 10.84 Bn |
| Mar 31, 2010 | 5.37 Bn |
| Dec 31, 2009 | 6.63 Bn |
| Sep 30, 2009 | 13.36 Bn |